134 related articles for article (PubMed ID: 17049228)
1. Significant variation in performance does not reflect the effectiveness of the cervical cancer screening programme in Finland.
Kotaniemi-Talonen L; Nieminen P; Hakama M; Seppänen J; Ikkala J; Martikainen J; Tarkkanen J; Toivonen T; Anttila A
Eur J Cancer; 2007 Jan; 43(1):169-74. PubMed ID: 17049228
[TBL] [Abstract][Full Text] [Related]
2. Large performance variation does not affect outcome in the Finnish cervical cancer screening programme.
Lönnberg S; Nieminen P; Kotaniemi-Talonen L; Kujari H; Melkko J; Granroth G; Vornanen M; Pietiläinen T; Arola J; Tarkkanen J; Luostarinen T; Anttila A
Cytopathology; 2012 Jun; 23(3):172-80. PubMed ID: 21255160
[TBL] [Abstract][Full Text] [Related]
3. Intensified screening among high risk women within the organised screening programme for cervical cancer in Finland.
Kotaniemi-Talonen L; Malila N; Anttila A; Nieminen P; Hakama M
Acta Oncol; 2011 Jan; 50(1):106-11. PubMed ID: 20560860
[TBL] [Abstract][Full Text] [Related]
4. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
5. Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.
van der Aa MA; Pukkala E; Coebergh JW; Anttila A; Siesling S
Int J Cancer; 2008 Apr; 122(8):1854-8. PubMed ID: 18067129
[TBL] [Abstract][Full Text] [Related]
6. Cervical cancer screening programme in Finland.
Anttila A; Nieminen P
Eur J Cancer; 2000 Nov; 36(17):2209-14. PubMed ID: 11072206
[TBL] [Abstract][Full Text] [Related]
7. The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional study in 10,669 Chinese women.
Zhao X; Wu Q; Wang X; Fu Y; Zhang X; Tian X; Cheng B; Lu B; Yu X; Lan S; Lu W; Ma D; Cheng X; Xie X
Clin Microbiol Infect; 2018 Dec; 24(12):1322-1327. PubMed ID: 29518562
[TBL] [Abstract][Full Text] [Related]
8. Effect of type of screening laboratory on population-based occurrence of cervical lesions in Finland.
Nieminen P; Hakama M; Tarkkanen J; Anttila A
Int J Cancer; 2002 Jun; 99(5):732-6. PubMed ID: 12115508
[TBL] [Abstract][Full Text] [Related]
9. A randomised public-health trial on automation-assisted screening for cervical cancer in Finland: performance with 470,000 invitations.
Nieminen P; Kotaniemi L; Hakama M; Tarkkanen J; Martikainen J; Toivonen T; Ikkala J; Luostarinen T; Anttila A
Int J Cancer; 2005 Jun; 115(2):307-11. PubMed ID: 15688388
[TBL] [Abstract][Full Text] [Related]
10. Prospective and randomised public-health trial on neural network-assisted screening for cervical cancer in Finland: results of the first year.
Nieminen P; Hakama M; Viikki M; Tarkkanen J; Anttila A
Int J Cancer; 2003 Jan; 103(3):422-6. PubMed ID: 12471627
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer screening programme in Finland with an example on implementing alternative screening methods.
Anttila A; Nieminen P
Coll Antropol; 2007 Apr; 31 Suppl 2():17-22. PubMed ID: 17600933
[TBL] [Abstract][Full Text] [Related]
12. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of
Lehtinen M; Lagheden C; Luostarinen T; Eriksson T; Apter D; Harjula K; Kuortti M; Natunen K; Palmroth J; Petäjä T; Pukkala E; Siitari-Mattila M; Struyf F; Nieminen P; Paavonen J; Dubin G; Dillner J
BMJ Open; 2017 Aug; 7(8):e015867. PubMed ID: 28821519
[TBL] [Abstract][Full Text] [Related]
13. HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial.
Kitchener HC; Almonte M; Thomson C; Wheeler P; Sargent A; Stoykova B; Gilham C; Baysson H; Roberts C; Dowie R; Desai M; Mather J; Bailey A; Turner A; Moss S; Peto J
Lancet Oncol; 2009 Jul; 10(7):672-82. PubMed ID: 19540162
[TBL] [Abstract][Full Text] [Related]
14. Primary cervical cancer screening with an HPV mRNA test: a prospective cohort study.
Sørbye SW; Fismen S; Gutteberg TJ; Mortensen ES; Skjeldestad FE
BMJ Open; 2016 Aug; 6(8):e011981. PubMed ID: 27515759
[TBL] [Abstract][Full Text] [Related]
15. Monitoring and evaluation of a model demonstration project for the control of cervical cancer in Nakhon Phanom province, Thailand.
Deerasamee S; Srivatanakul P; Sriplung H; Nilvachararung S; Tansuwan U; Pitakpraiwan P; Kaewkungwal J; Singhasivanon P; Nimnakorn P; Sankaranarayanan R
Asian Pac J Cancer Prev; 2007; 8(4):547-56. PubMed ID: 18260727
[TBL] [Abstract][Full Text] [Related]
16. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
[TBL] [Abstract][Full Text] [Related]
17. Early detection of CIN3 and cervical cancer during long-term follow-up using HPV/Pap smear co-testing and risk-adapted follow-up in a locally organised screening programme.
Luyten A; Buttmann-Schweiger N; Luyten K; Mauritz C; Reinecke-Lüthge A; Pietralla M; Meijer CJ; Petry KU
Int J Cancer; 2014 Sep; 135(6):1408-16. PubMed ID: 24519782
[TBL] [Abstract][Full Text] [Related]
18. Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.
Ogilvie GS; van Niekerk D; Krajden M; Smith LW; Cook D; Gondara L; Ceballos K; Quinlan D; Lee M; Martin RE; Gentile L; Peacock S; Stuart GCE; Franco EL; Coldman AJ
JAMA; 2018 Jul; 320(1):43-52. PubMed ID: 29971397
[TBL] [Abstract][Full Text] [Related]
19. Reasons for cervical cancer despite extensive screening.
Stenkvist B; Söderström J
J Med Screen; 1996; 3(4):204-7. PubMed ID: 9041486
[TBL] [Abstract][Full Text] [Related]
20. Non-progression of cervical intraepithelial neoplasia estimated from population-screening data.
Bos AB; van Ballegooijen M; van Oortmarssen GJ; van Marle ME; Habbema JD; Lynge E
Br J Cancer; 1997; 75(1):124-30. PubMed ID: 9000609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
